Published in:
Hindustan Times
Pubished on:
23 Mar 2016
To understand how India makes its own life difficult in the Ease of Doing Business stakes, one needs only to look at the $16-billion pharmaceutical sector, already in the news for a controversial ban on several household medications.
While the ban has hogged the headlines, there’s another, quiet recall of drugs set to happen, and it’s no less of a logistical, and avoidable, nightmare.
Every year, the government comes out with a revision of prices of essential medications, which is good and proper given that most Indians pay for healthcare from their own pockets and the authorities need to keep a beady eye on profiteering.